Tasigna

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
CP Wire
Thu, 11/14/24 - 10:25 pm
Azurity
Danziten
Ph+ CML
FDA
Novartis
Tasigna
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Thu, 11/14/24 - 07:28 pm
Azurity
Danziten
Ph+ CML
FDA
Novartis
Tasigna
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
CP WIre
Thu, 10/20/22 - 12:21 pm
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug
Thu, 10/20/22 - 12:27 pm
Novartis
Tasigna
generics
nilotinib
CML
Medicines Patent Pool
How Novartis' cancer drug Tasigna restores critical dopamine that's lost to Parkinson's disease
Fierce Biotech
Tue, 12/17/19 - 10:26 am
Tasigna
Novartis
Parkinson's Disease
New insights emerge in an effort to repurpose Novartis’ cancer drug Tasigna in Parkinson’s disease
Fierce Biotech
Wed, 03/13/19 - 04:36 pm
Novartis
Tasigna
Parkinson's Disease
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
Cancer drug could benefit Parkinson's patients, study shows
BioPharma Dive
Tue, 07/12/16 - 09:30 am
Parkinson's Disease
Novartis
Tasigna
Novartis Cancer Drug Shows Promise as Treatment for Parkinson's
Bloomberg
Mon, 10/19/15 - 09:58 am
Tasigna
Novartis
Parkinson's Disease
Tasigna Wins Over Gleevec in Ph+CML Patients
Drug Discovery and Development
Tue, 12/9/14 - 11:42 am
Tasigna
Gleevec
chronic myeloid leukemia
Novartis
Japanese officials: Novartis failed to report side effects of leukemia drug
Fierce Pharma
Mon, 05/12/14 - 11:56 am
Tasigna
Novartis
Japan
Tokyo hospital exec says Novartis employees deeply involved in leukemia-drug trial
Fierce Pharma
Mon, 03/17/14 - 05:11 pm
Novartis
Japan
Tasigna
J&J, Roche, Novartis tout key cancer-drug data at ASH
Fierce Pharma
Mon, 12/9/13 - 10:12 am
JNJ
Roche
Novartis
Imbruvica
Tasigna
CLL
Gazyva
Novartis Cannibalizes Gleevec to Boost New Cancer Drug
Bloomberg
Fri, 10/26/12 - 10:30 am
Novartis
Gleevec
leukemia
Tasigna
Novartis ends Tasigna trial in intestinal cancer
Yahoo/AP
Mon, 04/11/11 - 12:39 pm
Novartis
Tasigna
intestinal cancer
Novartis leukemia drug approved in Japan
Marketwatch
Tue, 12/21/10 - 09:59 am
Novartis
leukemia
Tasigna
Japan
Novartis: Tasigna surpasses Glivec in study
Fierce Pharma
Mon, 12/6/10 - 11:23 am
Tasigna
Glivec
Novartis
leukemia
Novartis wins FDA nod for broader Tasigna use
Fierce Pharma
Fri, 06/18/10 - 11:48 am
Tasigna
Novartis
cancer
FDA
Gleevac
Novartis' Tasigna gets FDA priority review
Reuters
Fri, 02/19/10 - 09:18 am
Tasigna
FDA
Novartis
leukemia

Pages